Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-28

Clinical Trial Update: Comparisons of the Effects of Solifenacin Versus Mirabegron on Autonomic System, Arterial Stiffness and Psychosomatic Distress and Clinical Outcomes [Phase 4]

View source ↗

Summary

Phase 4 trial comparing solifenacin and mirabegron on autonomic function, arterial stiffness, psychosomatic distress, and clinical outcomes in overactive bladde…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mirabegron (mirabegron)
  • Solifenacin (solifenacin)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Overactive Bladder Syndrome | Phase 4 | Status: COMPLETED